Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Huateng Pharma Elevates Diabetes Drug Development with High-Purity Anti-Diabetes Intermediates

    Nov 13, 2023, 08:55 AM by
    Huateng Pharma introduces advanced anti-diabetes intermediates, such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide, representing a major step in diabetes treatment. These high-purity compounds have the potential to revolutionize drug development. Huateng Pharma also offers CDMO services to promote collaboration in the pharmaceutical industry.
    Full story
  • NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

    Nov 10, 2023, 06:58 AM by
    NSF has announced that that Novozymes has become the world’s first company to implement NSF TraQtion software for managing the quality and compliance of raw materials used in the production of enzymes and proteins serving multiple industries.
    Full story
  • Medix Biochemica expands its infectious diseases antibody offering through the acquisition of ViroStat

    Nov 10, 2023, 06:58 AM by
    Medix Biochemica has acquired 100 percent of the shares of ViroStat.
    Full story
  • 1upHealth Ranked Number 35 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

    Nov 9, 2023, 08:51 AM by
    Full story
  • Kalderos Strengthens C-Suite by Naming New CFO, CTO and CISO

    Nov 9, 2023, 08:51 AM by
    Kalderos Strengthens C-Suite by Naming New CFO, CTO and CISO
    Full story
  • PacBio News: HiFi Consortium, Tertiary Partners, New RNA Kits

    Nov 9, 2023, 01:00 AM by User Not Found
    Bio-IT World | Pacific Bioscience made several announcements this week at the American Society of Human Genetics Annual Meeting in Washington D.C. The sequencing company announced a new consortium focused on quantifying the value of HiFi sequencing, launched a family of RNA sequencing kits, and named two new tertiary analysis partners.
    Full story
  • CCC Adds Clinical Trial Registries to RightFind Navigate Data Sources

    Nov 8, 2023, 09:15 AM by
    With Clinical Trial Registries, life science teams can save time with one-stop searching across clinical trial data, scientific literature and other data sources inside RightFind Navigate.
    Full story
  • AMADA WELD TECH INC Highlights AC Inverter Welding Power Supplies

    Nov 8, 2023, 09:15 AM by
    Full story
  • PharMerica Selects SinguLab to Deliver Pharmacogenomics Solutions for Facilities: Data-driven Risk Assessments and Proven PGx Program Best Practices Help Enhance Resident Care

    Nov 8, 2023, 09:15 AM by
    SinguLab®, a nationwide provider of precision medicine and diagnostics solutions, today announced a strategic partnership with PharMerica, a large-scale pharmacy company in the US, to power pharmacogenomics (PGx) insights, resources, and nationwide diagnostics support for all PharMerica clients. This partnership will help facilitate continuous, real-time analysis of potential medication risks, deliver ongoing PGx best practices education, and offer clinical providers the option to utilize SinguLab’s Partner Network for best-in-class PGx laboratory solutions.
    Full story
  • Big Pharma, Moderna on An AI-Empowered Era of Drug Discovery

    Nov 8, 2023, 01:00 AM by User Not Found
    Bio-IT World | In January, Heidi Rehm will take over the leadership of the Global Alliance for Genomics and Health, GA4GH, replacing out-going Chair Ewan Birney. Rehm sat down with Stan Gloss to talk about the mission of GA4GH and share areas of future focus for the latest episode of the Trends from the Trenches podcast.
    Full story
  • Custom Stainless Enclosures Provides 4Xxtreme® Electrical Enclosures with the Lowest Cost of Ownership

    Nov 7, 2023, 06:52 AM by
    Full story
  • Cotiviti to Share Innovative Approaches in Preventing Fraud, Waste, and Abuse at the 2023 NHCAA Annual Training Conference

    Nov 7, 2023, 06:52 AM by
    Cotiviti execs Erin Rutzler and Angela Mitchell are presenting tips for preventing fraud, waste, and abuse (FWA) at the 2023 National Health Care Anti-Fraud Association (NHCAA) Annual Training Conference, taking place Nov. 6-9 in Dallas, TX. During the show, Rutzler and Mitchell will discuss the role of AI/ML in curbing FWA, and share actionable strategies for leveraging prepay and postpay analytics to improve payment integrity.
    Full story
  • TrialAssure Uses Artificial Intelligence to Create Plain Language Summaries for 50,000 Studies Listed on ClinicalTrials.Gov

    Nov 7, 2023, 06:52 AM by
    TrialAssure, an AI-technology leader in advancing clinical trial results disclosure and data sharing in the pharmaceutical industry, announced today that it has taken the proactive effort to create and publish clinical trial results in plain language summary (PLS) format, posting directly to TrialResults.com. This includes plain language summaries for every clinical trial that has had results posted on the National Institutes of Health’s (NIH) ClinicalTrials.gov website since 2020 – nearly 50,000 documents.
    Full story
  • TriLink BioTechnologies® and Intellia Sign Multiyear Supply Agreement

    Nov 7, 2023, 06:52 AM by
    Full story
  • ResultsCX Partners with Department of Defense to Support Military Spouse Employment Initiative

    Nov 7, 2023, 06:52 AM by
    ResultsCX, a company that provides Customer Experience Management services across the healthcare industry, partnered with the Defense Department Spouse Education and Career Opportunities program and Military Spouse Employment Partnership (MSEP). Through this engagement, ResultsCX provides job opportunities for military spouses who often face employment barriers due to their challenging circumstances.
    Full story
  • Major study validates Owkin’s best in class AI diagnostic for colorectal cancer biomarker aimed at optimizing patient access to immunotherapy

    Nov 7, 2023, 06:52 AM by
    In a peer-reviewed study published today, a team of scientists from French-American techbio Owkin and pathology labs in France present a blind validation of MSIntuit™ CRC, a first-in-class AI-driven digital pathology diagnostic
    Full story
  • How AI is Transforming Drug Discovery: Bio-IT World Europe Participants to Share Groundbreaking Advances 29-30 November in London

    Nov 7, 2023, 06:52 AM by
    Bio-IT World Europe participants will discuss the many ways that AI is transforming drug discovery during the second annual conference and expo, taking place November 29-30 in London.
    Full story
  • PubHive Launches Local Literature Dashboard & Tailoring Workflows

    Nov 7, 2023, 06:52 AM by
    Local Literature Dashboard: Provides users with a single view of their allocated regions and activities they performed based on the configuration.
    Full story
  • Inizio Medical Calls for Urgent Action to Adopt AI in All Aspects of Healthcare Communication

    Nov 7, 2023, 06:52 AM by
    One of the world’s leading communication companies Inizio Medical has issued an urgent call to action for businesses to adopt AI in all aspects of healthcare communication or risk being left behind by their competitors.
    Full story
  • ‘Subway Map’ Approach To Finding Targeted Therapeutics For Lyme Disease

    Nov 7, 2023, 01:00 AM by User Not Found
    Bio-IT World | Scientists in Boston are flipping the script on the current antibiotic development paradigm by painstakingly choosing a good metabolic target for combatting Lyme disease. The typical approach has been to test vast numbers of chemicals against the culprit bacteria rather than design a compound to specifically go after one of its essential biological activities.
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68 (current)
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy